B. Guery

B. Guery, L. Senn, A. Kritikos, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery

C. Beigelman-Aubry, P. Vollenweider, N. Rufer, 2020, Frontiers in Immunology.

Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats

I. Tillie‐Leblond, B. Guery, A. Janin, 2007, European Respiratory Journal.

Chronic bronchial allergic inflammation increases alveolar liquid clearance by TNF-alpha -dependent mechanism.

I. Tillie‐Leblond, J. Pittet, B. Guery, 2002, American journal of physiology. Lung cellular and molecular physiology.

Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis

John O. Prior, B. Guery, G. Treglia, 2020, Diagnostics.

[Acute invasive pulmonary aspergillosis in chronic lung disease--a review].

I. Tillie‐Leblond, S. Nseir, B. Guery, 2006, Revue des maladies respiratoires.

Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia

S. Lancel, R. Neviere, K. Faure, 2007, Intensive Care Medicine.

Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa

F. Gottrand, L. Béghin, B. Guery, 2007, Respiratory research.

Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults.

C. Flateau, K. Faure, B. Guery, 2016, Medecine et maladies infectieuses.

A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit

B. Guery, H. Georges, O. Leroy, 2006, Intensive Care Medicine.

Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study

B. Guery, O. Hugli, O. Opota, 2021, Journal of General Internal Medicine.

High Level of Resistance to Levofloxacin of Streptococcus pneumoniae following Fluoroquinolone Therapy

B. Guery, S. Alfandari, T. d’Escrivan, 2003, Infection.

Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia

P. Devos, B. Guery, S. Alfandari, 2006, Intensive Care Medicine.

Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.

J. Mecsas, B. Guery, P. Tulkens, 2016, The Journal of infectious diseases.

Community‐Acquired Pneumonia in the Intensive Care Unit: Epidemiological and Prognosis Data in Older People

D. Thévenin, C. VandenBussche, B. Guery, 1999, Journal of the American Geriatrics Society.

Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs.

B. Guery, C. Mason, W. Summer, 1997, American journal of respiratory and critical care medicine.

Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.

J. Pittet, B. Guery, C. Mason, 2000, American journal of physiology. Lung cellular and molecular physiology.

Pulmonary stress injury within physiological ranges of airway and vascular pressures.

B. Guery, C. Mason, W. Summer, 1998, Journal of critical care.

Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.

S. Sorensen, M. Dupon, B. Guery, 2009, Medecine et maladies infectieuses.

Organisation de la réanimation en situation de pandémie de grippe aviaire

B. Régnier, B. Guidet, B. Guery, 2008, Archives de Pédiatrie.

Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study

B. Guery, B. Grandbastien, A. Croxatto, 2022, Journal of clinical medicine.

Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study

M. Wilcox, B. Guery, M. Vehreschild, 2019, Open forum infectious diseases.

Clostridium difficile infection trials: what is the primary endpoint?

B. Guery, 2019, The Lancet. Infectious diseases.

Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.

B. Polack, B. Guery, M. Derouazi, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Fluorescein-labeled dextran concentration is increased in BAL fluid after ANTU-induced edema in rats.

B. Guery, C. Mason, W. Summer, 1998, Journal of applied physiology.

Haemophilus parainfluenzae endocarditis in young adults.

K. Faure, B. Guery, A. Vincentelli, 2017, Medecine et maladies infectieuses.

FITC-ALBUMIN AS A MARKER FOR ASSESSMENT OF ENDOTHELIAL PERMEABILITY IN MICE: COMPARISON WITH125I-ALBUMIN

K. Faure, B. Guery, D. Boutoille, 2009, Experimental lung research.

Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance

J. Pittet, K. Faure, B. Guery, 2004, Intensive Care Medicine.

A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France

B. Guery, J. Lavigne, C. Couzigou, 2021, Journal of International Medical Research.

Pharmacokinetic analysis of an extended-pulsed fidaxomicin regimen for the treatment of Clostridioides (Clostridium) difficile infection in patients aged 60 years and older in the EXTEND randomized controlled trial.

M. Wilcox, B. Guery, I. Michon, 2020, The Journal of antimicrobial chemotherapy.

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

E. Hachulla, B. Guery, P. Clerson, 2014, Clinical Rheumatology.

Ventilation-Induced Lung Injury is Associated With an Increase in Gut Permeability

R. Neviere, D. Welsh, B. Guery, 2003, Shock.

Antibiotic Resistance

B. Guery, J. Boelens, 2022 .

Native aortic valve endocarditis due to Pseudomonas stutzeri in a 91-year-old woman.

B. Guery, F. Puisieux, C. Loiez, 2018, Medecine et maladies infectieuses.

Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

C. Uyttenhove, B. Ryffel, M. Chamaillard, 2014, American journal of respiratory and critical care medicine.

Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model

S. Nseir, K. Faure, E. Kipnis, 2011, Critical care.

P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells.

R. Matran, B. Harvey, K. Faure, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Establishment of a French surveillance system of Clostridiodes difficile infection: comparison of patient's characteristics with other national and European data.

N. Khanafer, P. Vanhems, B. Guery, 2021, Anaerobe.

Keratinocyte growth factor attenuates hydrostatic pulmonary edema in an isolated, perfused rat lung model.

C. Creusy, D. Welsh, B. Guery, 2001, American journal of physiology. Heart and circulatory physiology.

Exchange Transfusion for Severe Malaria

B. Guery, S. Alfandari, H. Georges, 2001, Infection.

Prophylaxis: Peace of Mind?

K. Faure, B. Guery, 2011 .

Beta-adrenergic modulation of lung fluid balance in acute P aeruginosa pneumonia in rats

B. Guery, L. Robriquet, Eric Kipris, 2011, Experimental lung research.

Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital

B. Guery, G. Prod'Hom, L. Senn, 2022, Antimicrobial Resistance and Infection Control.

Tatumella ptyseos Causing Human Sepsis: Report of the First Case in Switzerland and Review of the Literature

B. Guery, A. Croxatto, Guy Prodhom, 2018, SN Comprehensive Clinical Medicine.

[Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model].

F. Gottrand, L. Béghin, K. Faure, 2008, Medecine et maladies infectieuses.

Relative expression of Pseudomonas aeruginosa virulence genes analyzed by a real time RT-PCR method during lung infection in rats.

F. Gottrand, S. Auvin, B. Guery, 2005, FEMS microbiology letters.

Escherichia coli endotoxin reduces cytochrome aa3 redox status in pig skeletal muscle

S. Mordon, C. Chopin, B. Guery, 2000, Critical care medicine.

Isavuconazole brain penetration in cerebral aspergillosis.

L. Decosterd, B. Guery, P. André, 2019, The Journal of antimicrobial chemotherapy.

Development of a New Gastight Film Containing Evoh

B. Guery, R. Rebizak, T. Fouillet, 2014 .

Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association?

K. Faure, R. Dessein, B. Guery, 2013, Medecine et maladies infectieuses.

The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks

L. Delhaes, B. Guery, R. Prével, 2020, Frontiers in Cellular and Infection Microbiology.

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.

E. Kuijper, J. van Prehn, S. Tschudin-Sutter, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.

Clio, C. Campèse, S. Cauchemez, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

First Case of Cerebral Abscess Due to a Novel Nocardia Species in an Immunocompromised Patient

C. Flateau, K. Faure, B. Guery, 2012, Journal of Clinical Microbiology.

Vascular nosocomial Nocardia farcinica infection after arterial stenting in an immunocompetent patient.

S. Haulon, K. Faure, R. Dessein, 2011, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Mise au point Pneumonie virale sévère de l ’ immunocompétent Viral pneumonia in immunocompetent patients

K. Faure, B. Guery, H. Georges, 2004 .

Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia

B. Guery, C. Chidiac, M. Roussel-Delvallez, 1995, Antimicrobial agents and chemotherapy.

Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations

A. Koutsokera, C. Csajka, B. Guery, 2022, European Respiratory Review.

Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?

B. Guery, A. Brunel, 2017, Swiss medical weekly.

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment

C. Putensen, G. Auzinger, É. Azoulay, 2009, Intensive Care Medicine.

Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan

A. Standaert, S. Nseir, B. Guery, 2008, Clinical and Vaccine Immunology.

Reliability of quantitative cultures of protected specimen brush after freezing.

C. VandenBussche, B. Guery, H. Georges, 1996, American journal of respiratory and critical care medicine.

Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*

S. Lancel, K. Faure, B. Guery, 2011, Critical care medicine.

Early Antimicrobial Therapy for Sepsis: Does Each Hour Really Count?

T. Calandra, B. Guery, 2019, Seminars in Respiratory and Critical Care Medicine.

Pharmacokinetics of vancomycin during continuous hemodiafiltration

B. Guery, H. Georges, O. Leroy, 2005, Intensive Care Medicine.

Protective Role of Inhaled Nitric Oxide in Ischemia/Reperfusion and Endotoxin-Induced Inflammation

B. Guery, R. Nevière, 1999 .

MASSIVE ALVEOLAR THROMBIN ACTIVATION IN PSEUDOMONAS AERUGINOSA-INDUCED ACUTE LUNG INJURY

R. Neviere, B. Guery, X. Leroy, 2004, Shock.

State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans

P. Formenty, S. Hugonnet, J. Peiris, 2013, PLoS currents.

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

B. Souweine, J. Timsit, L. Bouadma, 2015, Intensive Care Medicine.

Metarhizium anisopliae, a means of fighting wireworms soil pests: results and outlook.

B. Guery, 2015 .

[Ebola and others, those viruses coming from far away].

K. Faure, B. Guery, B. Grandbastien, 2015, Reanimation : journal de la Societe de reanimation de langue francaise.

CHRONIC BRONCHIAL ALLERGIC INFLAMMATION INCREASES ALVEOLAR LIQUID CLEARANCE BY A TNF- αααα DEPENDENT MECHANISM.

I. Tillie‐Leblond, J. Pittet, B. Guery, 2002 .

Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance

K. Faure, B. Guery, X. Leroy, 2005, Respiratory research.

Clostridioides difficile Infection, Still a Long Way to Go

B. Guery, A. Croxatto, G. Prod'Hom, 2021, Journal of clinical medicine.

Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.

B. Guery, P. Tulkens, M. Mingeot-Leclercq, 2015, Pathogens and disease.

Rational approach in the management of Pseudomonas aeruginosa infections

T. Calandra, M. Bassetti, B. Guery, 2018, Current opinion in infectious diseases.

Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa

Gilles Bernot, Jean-Paul Comet, Benoit Guery, 2006, BMC Bioinformatics.

Effect of different stabilized preparations of peracetic acid on biofilm.

K. Faure, B. Guery, N. Loukili, 2006, The Journal of hospital infection.

Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa.

K. Faure, B. Guery, R. Courcol, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Deactivation of alveolar macrophages in septic neutropenic ARDS.

J. Blache, R. Bouabdallah, J. Mege, 2003, Chest.

Optimising Antimicrobial Stewardship to Tackle Clostridioides difficile Infection and Improve Patient Outcomes

B. Guery, J. Reinoso, 2022, EMJ Microbiology & Infectious Diseases.

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital

B. Guery, B. Grandbastien, F. Wallet, 2017, Infection.

[Cefoxitin and ESBL].

K. Faure, R. Dessein, B. Guery, 2012, Medecine et maladies infectieuses.

Diagnostic and therapy of severe Clostridioides difficile infections in the ICU

S. Tschudin-Sutter, B. Guery, F. Barbut, 2020, Current opinion in critical care.

Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France

B. Dervaux, X. Lenne, B. Guery, 2017, PloS one.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.

V. Anttila, B. Guery, M. Vehreschild, 2017, The Lancet. Infectious diseases.

Infections I

D. Grujičić, T. Inglis, C. Brun-Buisson, 2011, Intensive Care Medicine.

Factors associated with recurrence of catheter-related bloodstream infections in home parenteral nutrition patients

G. Béraud, X. Lenne, K. Faure, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?

B. Guery, E. Boyle, C. Herbaux, 2017, Medecine et maladies infectieuses.

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

H. Sokol, N. Kapel, B. Guery, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.

P. Marquet, P. Vest, B. Guery, 1998, Journal of forensic sciences.

Clostridioides difficile: diagnosis and treatments

B. Guery, F. Barbut, T. Galpérine, 2019, BMJ.

Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit

P. Devos, B. Guery, H. Georges, 2005, Infection.

Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score

D. Thévenin, C. VandenBussche, B. Guery, 1996, Intensive Care Medicine.

Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs.

P. Devos, D. Thévenin, C. VandenBussche, 1999, Chest.

Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia.

B. Guery, S. Alfandari, P. Choisy, 1999, Journal of critical care.

Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data.

D. Thévenin, C. VandenBussche, B. Guery, 1997, American journal of respiratory and critical care medicine.

Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study

B. Guery, L. Senn, M. Papadimitriou-Olivgeris, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia

B. Guery, L. Senn, M. Papadimitriou-Olivgeris, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats.

S. Mordon, R. Neviere, C. Chopin, 2000, American journal of physiology. Heart and circulatory physiology.

Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor

J. Blache, J. Mege, D. Blaise, 2008, Critical care.

Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit

J. Dubuisson, H. Touzet, F. Maurier, 2019, Journal of Clinical Virology.

Long-Chain Polyunsaturated Fatty Acids Modulate Lung Inflammatory Response Induced by Pseudomonas aeruginosa in Mice

F. Gottrand, S. Auvin, B. Guery, 2005, Pediatric Research.

In the name of common sense: EUCAST breakpoints and potential pitfalls.

B. Guery, S. Meylan, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

‘In the name of common sense’ – Author's reply

B. Guery, S. Meylan, 2020 .

Biphasic lung injury during Streptococcus pneumoniae infection in a murine model.

P. Gosset, K. Faure, B. Guery, 2017, Medecine et maladies infectieuses.

The aliphatic amidase AmiE is involved in regulation of Pseudomonas aeruginosa virulence

S. Chevalier, O. Lesouhaitier, M. Feuilloley, 2017, Scientific Reports.

Evaluation de la prescription antibiotique dans un service de réanimation polyvalente

B. Guery, É. Senneville, S. Alfandari, 1998 .

Long-Term Consequences of COVID-19: A 1-Year Analysis

L. Alberio, M. Preisig, R. D. Du Pasquier, 2023, Journal of clinical medicine.

Predisposing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheotomy.

B. Guery, S. Alfandari, H. Georges, 2000, Chest.

Identification of Biofilm-Associated Cluster (bac) in Pseudomonas aeruginosa Involved in Biofilm Formation and Virulence

V. Molle, A. Filloux, B. Guery, 2008, PloS one.

Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System

P. Gosset, B. Polack, K. Faure, 2005, Infection and Immunity.

Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration.

P. Devos, S. Nseir, B. Guery, 2006, Journal of critical care.

Inhaled NO preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model.

B. Guery, N. Viget, G. Beaucaire, 1999, Journal of applied physiology.

Fluorescence imaging microscopy of leukocytes-endothelium interaction in rat mesenteric microcirculation after endotoxin injection: role of inhaled nitric oxide

Bruno Buys, Guy Dhelin, Claude Chopin, 1999, European Conference on Biomedical Optics.

Dry alginate beads for fecal microbiota transplantation: from model strains to fecal samples.

J. Schrenzel, B. Guery, F. Sadeghipour, 2023, International journal of pharmaceutics.

Recurrent Bacteremia, a Complication of Cyanoacrylate Injection for Variceal Bleeding: Report of Two Cases and Review of the Literature

G. Béraud, F. Durand, C. Flateau, 2009, Case Reports in Medicine.

Preparedness of healthcare workers at French Ebola referral centres

P. Brouqui, P. Peretti-Watel, B. Guery, 2015, New Microbes and New Infections.

Promises and limitations of the bronchoscopic microsampling probe.

B. Guery, Eric Kipnis, J. Wiener‐Kronish, 2007, Chest.

Exploring ways to improve CDI outcomes.

B. Guery, T. Galpérine, Benoit Guery, 2018, Medecine et maladies infectieuses.

Fecal Microbiota Transplantation: Do We Need Harmonization?

H. Sokol, B. Guery, T. Galpérine, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Critical oxygen extraction in piglet hindlimb is impaired after inhibition of ATP-sensitive potassium channels.

C. Chopin, S. Cain, B. Guery, 1996, Advances in experimental medicine and biology.

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship

A. Le Gouellec, T. Grandjean, Perrine Bortolotti, 2016, BMC Microbiology.

Diguanylate cyclase DgcP is involved in plant and human Pseudomonas spp. infections.

A. Filloux, B. Guery, C. Ramos, 2015, Environmental microbiology.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses

B. Guery, M. Vehreschild, A. Karas, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.

B. Guery, B. Grandbastien, A. Croxatto, 2022, Infectious diseases now.

Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats.

B. Guery, C. Mason, W. Summer, 1996, Critical care medicine.

A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock

P. Devos, K. Faure, B. Guery, 2008, Intensive Care Medicine.

Analysis of Costs Attributable to an Outbreak of Severe Acute Respiratory Syndrome at a French Hospital

Y. Yazdanpanah, B. Dervaux, X. Lenne, 2006, Infection Control & Hospital Epidemiology.

Practice guidelines for acute bacterial meningitidis (except newborn and nosocomial meningitis).

F. Raffi, B. Guery, B. Lina, 2009, Medecine et maladies infectieuses.

Soluble TREM-1 and the diagnosis of pneumonia.

B. Guery, H. Georges, O. Leroy, 2004, The New England journal of medicine.

Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023

B. Guery, P. Halfon, S. Serrano-Villar, 2023, Journal of Virus Eradication.

Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis

B. Guery, P. Tozzi, P. Monney, 2023, Infection.

Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis.

John O. Prior, D. Rotzinger, Guillaume Fahrni, 2023, European journal of internal medicine.

The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia

B. Guery, P. Monney, L. Senn, 2022, Frontiers in Cardiovascular Medicine.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses

B. Guery, M. Vehreschild, A. Karas, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Fungal aero-decontamination efficacy of mobile air-treatment systems.

L. Delhaes, B. Guery, N. Loukili, 2011, Medical mycology.

Redox status of cytochrome a,a3: a noninvasive indicator of dysoxia in regional hypoxic or ischemic hypoxia.

S. Mordon, C. Chopin, B. Guery, 1999, Critical care medicine.

[Surgical antimicrobial prophylaxis: compliance to guidelines and impact of targeted information program].

B. Guery, S. Soubrier, S. Alfandari, 2005, Annales francaises d'anesthesie et de reanimation.

Role of Cerebral Imaging on Diagnosis and Management in Patients With Suspected Infective Endocarditis

B. Guery, P. Tozzi, P. Monney, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The role of early defervescence in ruling out infective endocarditis: a cohort study.

B. Guery, P. Tozzi, P. Monney, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases

R. Favory, B. Guery, A. Goffard, 2014, Journal of Clinical Virology.

Ebola et autres, ces virus venus d’ailleurs

K. Faure, B. Guery, B. Grandbastien, 2014, Reanimation : journal de la Societe de reanimation de langue francaise.

Coronavirus: need for a therapeutic approach

B. Guery, S. van der Werf, 2013, The Lancet Infectious Diseases.

Is a chlorine dioxide wiping procedure suitable for the high-level disinfection of nasendoscopes?

B. Guery, O. Gaillot, D. Chevalier, 2017, Journal of infection prevention.

Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

C. Uyttenhove, B. Ryffel, M. Chamaillard, 2014, American journal of respiratory and critical care medicine.

Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection.

F. Gottrand, B. Guery, C. Galabert, 2009, Journal of NutriLife.

Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.

A. Imberty, David Redelberger, S. de Bentzmann, 2014, Journal of medicinal chemistry.

Organisation de la réanimation en situation de pandémie de grippe aviaire

B. Régnier, B. Guery, C. Chouaid, 2007, Médecine et Maladies Infectieuses.

Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*

S. Lancel, K. Faure, B. Guery, 2011, Critical care medicine.

Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort

P. Vollenweider, C. Bertelli, B. Guery, 2023, BMC Infectious Diseases.

Infective endocarditis, is there a goal beyond antibiotics and surgery?

B. Guery, M. Papadimitriou-Olivgeris, 2021, European journal of internal medicine.

Beta-adrenergic modulation of lung fluid balance in acute P aeruginosa pneumonia in rats

B. Guery, L. Robriquet, E. Kipris, 2011, Experimental Lung Research.

Vaccinal status of healthcare students in Lille.

B. Guery, P. Deruelle, D. Gosset, 2013, Medecine et maladies infectieuses.